However , in the 37 patients with a baseline estimated daily salt intake greater than 10 g and baseline systolic blood pressure ( SBP ) ranging from 150 to 200 mm Hg , SBP was lower ( P < 0.05 ) and SBP reduction was greater ( P < 0.05 ) 4 weeks after starting combination therapy in those receiving ARB/TZ treatment .